WEBINAR INVITATION Therapies & Hope for LMNA-related DCM Patients  During this webinar, organized by DCM foundation, critical information regarding genetic components of dilated cardiomyopathy, and Pfizer’s exciting Phase 3 Clinical Trial for which they are recruiting patients with the LMNA variant will be shared. Topics of the webinar will include: – Genetics and progressive stages of DCM – Diagnosis, Evaluation of Family Disease Risk, and Treatment – Explanation of Pfizer’s Phase 3 Clinical Trial for LMNA patients – A period of interactive Q&A will follow the presentation We hope you can join DCM foundation on this interesting webinar (recorded version). Date/Time: May 18, 2022 06:00 PM in Eastern Time (US and Canada) *Note: All registrants will receive a webinar recording after the event.  Speaker: Calum MacRae, MD, PhD from Brigham and Women’s Hospital, Boston Register for free (closed) – watch the recorded version  |
Therapies & Hope for LMNA-related DCM Patients
Show Your Support
Every contribution, regardless of its amount, fuels crucial efforts in research, medical education, patient advocacy, and raising awareness about LMNA cardiac diseases.
You can make a difference in various ways: by committing as a regular monthly donor, offering a single donation, organizing fundraising events both online and in person, contributing to our special tribute funds, or through your unique fundraising initiatives!
DonateDonateYou can make a difference in various ways: by committing as a regular monthly donor, offering a single donation, organizing fundraising events both online and in person, contributing to our special tribute funds, or through your unique fundraising initiatives!